Biography:
Dr. Philip Hemken, Ph.D., is a Principal Research Scientist in the Diagnostics Division of Abbott Laboratories. He manages the Protein Engineering team within Global Biologics Discovery. He got his BSc in Microbiology (Chemistry Minor) from Iowa State University of Science and Technology in 1986, MA in Biotechnology from Washington University in St. Louis in 1991, and Ph.D. in Molecular, Cellular, and Developmental Biology from Iowa State University of Science and Technology in 1996 followed by a Postdoc in the Biology Division at Argonne National Laboratories (1996‐1997). Currently, Dr. Hemken manages the Protein Engineering team in the Global Biologics Discovery organization at Abbott Laboratories (2016‐present). Dr. Hemken started in the Abbott Diagnostics Division at Abbott in 1997 working in product support (1997‐1998), followed by Molecular Diagnostics (1998‐2004), and Automated Immunoassay Development (2005‐2016). He has completed 14 immunoassay prototyping projects and managed the production of recombinant biologics for 27 immunoassay development projects. Dr. Hemken has 28 publications, 38 patent applications with 13 issued patents. Dr. Hemken resides in Pleasant Prairie, WI, and enjoys spending year‐round time with his wife Ann at their lake home in Northern Wisconsin hiking, biking, swimming, and skiing. He also enjoys woodworking and antique cars.
Title : Abbott diagnostics: COVID-19 inactivation, nucleocapsid antigen automated immunoassay development, and variant testing for automated and lateral flow assays binaxnow™ and panbio™